Discontinuation report RIVA-OLMESARTAN
Report ID | 81926 |
Drug Identification Number | 02471353 |
Brand name | RIVA-OLMESARTAN |
Common or Proper name | Riva-olmesartan 20mg |
Company Name | LABORATOIRE RIVA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 & 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for discontinuation | Raw material availability |
Anticipated discontinuation date | 2019-04-17 |
Actual discontinuation date | 2019-04-17 |
Remaining supply date | 2019-04-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-04-18 | English | Compare |
v2 | 2019-04-17 | French | Compare |
v1 | 2019-04-17 | English | Compare |
Showing 1 to 3 of 3